1 day Ago
Copy link Copied Copy link Copied Subscribe to gift this article Gift 5 articles to anyone you choose each month when you subscribe. Already a subscriber? Login EBR Systems, the heart device hopeful heavily backed by high-profile investors including Mark Carnegie, Bill Ferris and several major superannuation funds, has secured approval from authorities in the United States to begin selling its technology within months. The Food and Drug Administration approval means the company can begin generating revenues.
It’s wireless pacing system prevents heart failure, a market that could be worth as much as $6 billion. Copy link Copied Copy link Copied Subscribe to gift this article Gift 5 articles to anyone you choose each month when you subscribe. Already a subscriber? Login Introducing your Newsfeed Follow the topics, people and companies that matter to you.
Latest In Healthcare & fitness Fetching latest articles Most Viewed In Companies BOSS Financial Review.
